Media Summary: Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; mRNA-1273 Clinical Development; Pfizer/BioNTech COVID-19 ... Overview of post-marketing safety surveillance Epidemiology of individuals at increased risk of COVID-19 disease. Introduction; Overview of myocarditis and pericarditis; Update on COVID-19 vaccine safety, including myocarditis after mRNA ...
August 2020 Acip Meeting Welcome - Detailed Analysis & Overview
Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; mRNA-1273 Clinical Development; Pfizer/BioNTech COVID-19 ... Overview of post-marketing safety surveillance Epidemiology of individuals at increased risk of COVID-19 disease. Introduction; Overview of myocarditis and pericarditis; Update on COVID-19 vaccine safety, including myocarditis after mRNA ... Introductions; BNT-162b2 COVID-19 vaccine BLA safety and efficacy data. Modeling allocation strategies for the initial COVID-19 vaccine supply Work Group interpretation Prioritization and Work Group ... Introduction; Overview of safety with Janssen's COVID-19 vaccine (Ad26.COV2.S); Update on thromboembolic events, COVID-19 ...
Introduction; Update on SARS-CoV-2 Variants and the Epidemiology of COVID-19; Immunology of SARS-CoV-2 variants; Updates ... Introduction; Pathogenesis and Management of Thrombosis with Thrombocytopenia Syndrome (TTS); Thrombosis with ... Introduction; Updates on vaccine effectiveness of COVID-19 booster dose; Updates on safety of COVID-19 booster dose; VaST ... Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; Overview of COVID-19 vaccine safety; Enhanced vaccine safety ...
